Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DV Biomed Co's share price for the quarter that ended in Dec. 2025 was NT$59. DV Biomed Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 24.3 Mil. Therefore, DV Biomed Co's market cap for the quarter that ended in Dec. 2025 was NT$1,436.6 Mil.
DV Biomed Co's quarterly market cap
increased
from Dec. 2024 (NT$433.8 Mil) to Jun. 2025 (NT$1,454.7 Mil) but then
declined
from Jun. 2025 (NT$1,454.7 Mil) to Dec. 2025 (NT$1,436.6 Mil).
DV Biomed Co's annual market cap
declined
from Dec. 2023 (NT$2,914.8 Mil) to Dec. 2024 (NT$433.8 Mil) but then
increased
from Dec. 2024 (NT$433.8 Mil) to Dec. 2025 (NT$1,436.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DV Biomed Co's Enterprise Value for Today is NT$731.9 Mil.
DV Biomed Co (ROCO:6539) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DV Biomed Co Market Cap Related Terms
DV Biomed Co Market Cap Historical Data
* Premium members only.
The historical data trend for DV Biomed Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DV Biomed Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DV Biomed Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DV Biomed Co's Market Cap distribution charts can be found below:
* The bar in red indicates where DV Biomed Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DV Biomed Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DV Biomed Co (ROCO:6539) has a Market Cap of NT$1,014.2 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DV Biomed Co and its competitors. According to the industry distribution chart, DV Biomed Co ranks #753 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 73.7%.
Is DV Biomed Co's Market Cap too high?
DV Biomed Co's current Market Cap is NT$1,014.2 Mil. Based on the distribution chart, DV Biomed Co ranks #753 out of 1022 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DV Biomed Co has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DV Biomed Co's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, DV Biomed Co ranks #753 out of 1022 companies for Market Cap. This places DV Biomed Co in the lower half of its industry. The industry median Market Cap is 221.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 221.60, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DV Biomed Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 221.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DV Biomed Co's current Market Cap is NT$1,014.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DV Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, DV Biomed Co (ROCO:6539) is currently considered Possible Value Trap. The stock's GF Value™ is NT$70.47, compared to a current price of NT$41.65 — trading 40.9% below its estimated fair value. The current Market Cap is NT$1,014.2 Mil. DV Biomed Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DV Biomed Co (ROCO:6539), the current Market Cap is NT$1,014.2 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DV Biomed Co (ROCO:6539) Overvalued in 2026?
Based on GuruFocus' analysis, DV Biomed Co stock appears to be undervalued.
The current stock price of NT$41.65 is trading 40.9% below its estimated GF Value™ of NT$70.47.
GuruFocus considers DV Biomed Co to be Possible Value Trap.
Key valuation signals for ROCO:6539:
Market Cap: NT$1,014.2 Mil
GF Value™: NT$70.47 vs. price of NT$41.65 (40.9% below fair value)
No single metric tells the full story. See the ROCO:6539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DV Biomed Co Ltd provides medical supplies, skincare, and healthcare products. Its products include Perfectin and L'AMOUR Isis. The company also provides medical materials and needles (medicine), and healthcare products.
68GF Score
Get the complete analysis for ROCO:6539
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6539 has been successfully added to your 
